Emerald Health Therapeutics, Inc. has entered into a license with Indena S.p.A. of Milan, Italy, bearing certain exclusivity rights in Canada to use Indena’s cannabidiol (“CBD”) extraction technology, and contract manufacturing services for CBD extraction. In addition, Emerald has obtained exclusive use of Indena’s proprietary Phytosome® technology for the purpose of developing novel cannabinoid-based products subject to a minimum volume agreement.
Indena is the one of the world’s leading companies in the identification, development, and production of plant-derived active ingredients for the pharmaceutical, health food, and personal care industries. The company is adapting an existing proprietary extraction process to facilitate hemp extraction and will exclusively provide Emerald in Canada with this highly optimized process for extracting and isolating CBD to manufacture cannabinoid-based products. With multiple international large-scale extraction facilities, Indena will be the exclusive third party manufacturing supplier of CBD for Emerald. Emerald will use this CBD in its production of certain product lines.
Emerald and Indena have also established a research collaboration to assess the use of Indena’s Phytosome® technology in combination with various cannabinoids. The agreement provides Emerald with exclusive access to certain of Indena’s scientifically validated, commercially available Phytosome® formulations and plant-based technology that is designed to enhance solubility of compounds that are usually poorly absorbed by the body, such as cannabinoids. For Emerald, evaluating and securing superior technologies like Phytosome® is an important aspect of its objective to develop differentiated and effective cannabinoid-based products to improve human health.
“Emerald is one of the few Licensed Producers in Canada focused on applying proprietary innovation to improve the medical applications of cannabinoids, which is fully aligned with Indena’s scientific approach to phytochemical research,” said Stefano Togni, Business Development and Licensing Director of Indena. “We believe that both companies’ approaches to quality and innovation will create an exciting partnership that will add value to the industry and better serve patients and consumers who look for excellence in their products and predictive health outcomes.”
“Indena is one of the oldest and most established extraction businesses in the world. They have served international pharmaceutical companies with natural anti-cancer ingredients. They are one of the leaders in nutraceutical products. With multiple extraction-related deals announced, our comprehensive and cohesive international strategy for cannabis and hemp extraction is unfolding. We look forward to impactful cannabinoid product development advancements in 2019.”, the company stated.
For more information:
Emerald Health Therapeutics
Tel: 1.800.757.3536
Fax: 1.855.623.3325
[email protected]
emeraldhealth.ca
Indena
indena.com
